Eledon Pharmaceuticals (ELDN) Change in Account Payables (2016 - 2017)
Historic Change in Account Payables for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q1 2017 value amounting to -$154000.0.
- Eledon Pharmaceuticals' Change in Account Payables fell 12271.39% to -$154000.0 in Q1 2017 from the same period last year, while for Mar 2017 it was -$1.6 million, marking a year-over-year decrease of 400.52%. This contributed to the annual value of -$778000.0 for FY2016, which is 27562.08% down from last year.
- Latest data reveals that Eledon Pharmaceuticals reported Change in Account Payables of -$154000.0 as of Q1 2017, which was down 12271.39% from -$456000.0 recorded in Q4 2016.
- Eledon Pharmaceuticals' Change in Account Payables' 5-year high stood at $2.7 million during Q1 2015, with a 5-year trough of -$1.8 million in Q2 2015.
- For the 5-year period, Eledon Pharmaceuticals' Change in Account Payables averaged around -$46785.7, with its median value being -$222500.0 (2014).
- As far as peak fluctuations go, Eledon Pharmaceuticals' Change in Account Payables skyrocketed by 23446.12% in 2015, and later crashed by 523333.33% in 2016.
- Eledon Pharmaceuticals' Change in Account Payables (Quarter) stood at -$926000.0 in 2013, then decreased by 21.38% to -$1.1 million in 2014, then skyrocketed by 60.5% to -$444000.0 in 2015, then dropped by 2.7% to -$456000.0 in 2016, then skyrocketed by 66.23% to -$154000.0 in 2017.
- Its last three reported values are -$154000.0 in Q1 2017, -$456000.0 for Q4 2016, and -$960000.0 during Q3 2016.